CTBI(CTBI)
CTBI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $313M | $326M |
| Low | $311M | $321M |
| High | $315M | $330M |
| EBITDA Avg | $115M | $120M |
| Low | $114M | $118M |
| High | $116M | $121M |
| EBIT Avg | $110M | $114M |
| Low | $109M | $113M |
| High | $111M | $116M |
| Net Income Avg | $116M | $117M |
| Low | $114M | $117M |
| High | $116M | $117M |
| EPS Avg | $6.39 | $6.47 |
| Low | $6.33 | $6.45 |
| High | $6.45 | $6.50 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $80M | $80M | $79M | $81M | $83M | $84M |
| Low | $79M | $79M | $78M | $80M | $82M | $83M |
| High | $80M | $80M | $79M | $81M | $83M | $84M |
| EBITDA Avg | $29M | $29M | $29M | $30M | $30M | $31M |
| Low | $29M | $29M | $29M | $30M | $30M | $31M |
| High | $30M | $30M | $29M | $30M | $31M | $31M |
| EBIT Avg | $28M | $28M | $28M | $28M | $29M | $29M |
| Low | $28M | $28M | $28M | $28M | $29M | $29M |
| High | $28M | $28M | $28M | $28M | $29M | $29M |
| Net Income Avg | $30M | $29M | $28M | $29M | $30M | $30M |
| Low | $30M | $29M | $28M | $29M | $30M | $30M |
| High | $31M | $30M | $28M | $29M | $30M | $30M |
| EPS Avg | $1.65 | $1.61 | $1.55 | $1.59 | $1.66 | $1.67 |
| Low | $1.63 | $1.58 | $1.54 | $1.58 | $1.65 | $1.66 |
| High | $1.70 | $1.63 | $1.55 | $1.60 | $1.67 | $1.67 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |